Archives

by in
Entry Author Date Location
Third Rock’s Ninepoint Medical Grows Up, Plans $35M Series B 05/16/13 Boston
Foresite Capital Closes $100M Fund for Late-Stage Biotechs 01/31/13 San Francisco
Exclusive: Skyline Ventures Cuts Partners, Postpones Fundraising 10/26/12 National
Lux Bio Resurfaces With Defined Path for Pill for Rare Eye Disease 07/09/12 New York
Biotech Lagging Behind Go-Go Web Valuations, Survey Says 03/20/12 National
Charles River, FirstFuel, Quiet Logistics, & More Boston Deal News 02/29/12 Boston
Enanta, Satori, Vertex & More of the Week’s Life Sciences Newsmakers 02/24/12 Boston
Satori Snaps Up $15M for Alzheimer’s Drugs 02/23/12 Boston
Satori Pharmaceuticals Lands $15,000,000 New Financing 02/23/12 Boston
Prospect Venture Partners’ Alex Barkas Dies Suddenly 11/22/11 San Francisco
DFINE Obtains $25,000,000 New Financing Round 11/08/11 San Francisco
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better 10/24/11 National
TOPICA Pharmaceuticals Receives $27,000,000 Series B Financing 10/18/11 San Francisco
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug 07/21/11 San Diego
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
$7M for Satori Pharmaceuticals 01/04/11 Boston
Amira Cuts Half of Staff, Scientific Founders Exit as Company Seeks to Conserve Cash 11/23/10 San Diego
Bay State Startup Investing Rises to $199M in October; Industrial and Energy Sectors Help Plump Up the Total 11/17/10 Boston
Complete Genomics Sets IPO Price Range 10/26/10 San Francisco
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
NinePoint Medical Raises $33M A Round to Develop New Diagnostic Devices 10/14/10 Boston
NinePoint Medical Receives $33,000,000 Series A Funding Round 10/14/10 Boston
Pathwork Diagnostics Lands $30,000,000 Series C Financing Round 10/06/10 San Francisco
Complete Genomics Adds $39M 08/19/10 San Francisco
Complete Genomics Receives $39,000,000 Series E Financing Round 08/19/10 San Francisco
Genentech Inks Antibody Deal, Cytokinetics Sticks With Science First, BioMarin Scraps Drug, & More Bay Area Life Sciences News 08/06/10 San Francisco
Complete Genomics Seeks IPO 08/02/10 San Francisco
DFINE Garners $36,200,000 New Financing 07/07/10 San Francisco
Baxano Obtains $30,000,000 Series C Funding Round 06/22/10 San Francisco
NGM Biopharmaceuticals Obtains $51,000,000 Series B Funding Round 03/15/10 San Francisco
Page 1 of 3 next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.